JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258748

Human UFL1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

UFL1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon2 and 5 bp deletion in exon2 and 7 bp deletion in exon2.

View Alternative Names

E3 UFM1-protein ligase 1, MAXER, NLBP, Novel LZAP-binding protein, Regulator of C53/LZAP and DDRGK1, UFL1, KIAA0776, RCAD, E3 UFM1-protein transferase 1, Multiple alpha-helix protein located at ER

4 Images
Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)
  • Sanger seq

Unknown

Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)

Allele-1 : 7 bp deletion in exon2

Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)
  • Sanger seq

Unknown

Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)

Allele-2 : 5 bp deletion in exon2

Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)
  • Sanger seq

Unknown

Sanger Sequencing - Human UFL1 knockout HEK-293T cell lysate (AB258748)

Allele-3 : 2 bp deletion in exon2

Western blot - Human UFL1 knockout HEK-293T cell lysate (AB258748)
  • WB

Lab

Western blot - Human UFL1 knockout HEK-293T cell lysate (AB258748)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Performed under reducing conditions.

In Western blot, ab325397 was shown to bind specifically to UFL1. Target of interest was observed at 40, 80 kDa in wild-type HEK-293 cell lysates (lane 3) with no signal observed at this size in UFL1 knockout cell line (lane 4) (lane 4, knockout cell line ab266500 / knockout cell lysate ab258748).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-UFL1 antibody [EPR29684-84] (<a href='/en-us/products/primary-antibodies/ufl1-antibody-epr29684-84-ab325397'>ab325397</a>) at 1/1000 dilution

Lane 1:

EL4 (mouse lymphoma T lymphocyte) whole cell lysate at 50 µg

Lane 2:

B16-F10 (mouse skin melanoma cell) whole cell lysate at 50 µg

Lane 3:

Wild-type HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 50 µg

Lane 4:

Western blot - Human UFL1 knockout HEK-293T cell lysate (ab258748) at 50 µg

Lane 5:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 50 µg

Lane 6:

HaCaT (human skin keratinocyte) whole cell lysate at 50 µg

Lane 7:

K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 50 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 40 kDa,80 kDa,36 kDa

false

Exposure time: 15s

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon2 and 5 bp deletion in exon2 and 7 bp deletion in exon2.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258748-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258748-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human UFL1 knockout HEK293T cell lysate", "number":"AB258748-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UFL1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UFL1 also known as E3 ubiquitin-protein ligase UFL1 is a protein involved in the post-translational modification process called ufmylation. This protein has a molecular mass of approximately 34 kDa and facilitates the attachment of the ubiquitin-fold modifier 1 (UFM1) to target proteins. UFL1 is widely expressed in various tissues including the liver heart and kidney. It forms part of a complex that includes UFM1 UBA5 and UFC1 which are all essential for its function.
Biological function summary

UFL1 regulates proteins' stability and activity by ufmylation in the endoplasmic reticulum (ER) stress response. This protein modifies select substrates enhancing their role in maintaining cellular homeostasis under stress conditions. UFL1 works closely with UFM1 and is part of a complex that targets specific proteins indicating its role in maintaining proper cellular conditions during ER stress. This modification mechanism is important for cells to adapt to changing environments and sustain normal function.

Pathways

UFL1 plays a role in the ER stress response and protein folding pathways. It operates alongside other proteins including UFM1 which is critical in these processes. UFL1 modulates pathways linked with cellular responses to stress and survival. It interacts with proteins like CDK5 suggesting a role in cellular processes that require precise regulation during stress conditions. Such interactions further integrate UFL1 into overarching cellular survival strategies.

UFL1 has implications in cancer and neurodegenerative diseases. Dysregulation of ufmylation where UFL1 is an important player shows links to tumor progression and survival mechanisms in cancer. UFL1 is also connected to pathological protein aggregation relevant in neurodegenerative diseases. Its interaction with proteins involved in ER stress response suggests a relationship to these conditions. Understanding UFL1's function in these diseases is important for identifying therapeutic targets.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com